Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPL-2003 (Minocycline) in Adolescents with OCD
NCT00515255Phase 2Terminated
- Sponsor
- Neuropharm
- Start
- Jul 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minocycline in obsessive compulsive disorder (OCD), sponsored by Neuropharm. Primary endpoint: Change in Children's Yale-Brown Obsessive Compulsive Scale. Started Jul 2007; status: terminated.
02
Drugs
minocycline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00515255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515255.